117 related articles for article (PubMed ID: 31103522)
21. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
22. Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.
Okyere B; Creasey M; Lebovitz Y; Theus MH
J Neurosci Methods; 2018 Jan; 293():86-96. PubMed ID: 28935424
[TBL] [Abstract][Full Text] [Related]
23. Revascularization for acute ischemic stroke is safe for rivaroxaban users.
Kimura S; Ogata T; Fukae J; Okawa M; Higashi T; Iwaasa M; Inoue T; Tsuboi Y
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):e427-31. PubMed ID: 25149204
[TBL] [Abstract][Full Text] [Related]
24. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.
Parry TJ; Huang Z; Chen C; Connelly MA; Perzborn E; Andrade-Gordon P; Damiano BP
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):720-6. PubMed ID: 21986468
[TBL] [Abstract][Full Text] [Related]
25. Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice.
Wu TC; Chan JS; Lee CY; Leu HB; Huang PH; Chen JS; Lin SJ; Chen JW
Cardiovasc Diabetol; 2015 Jun; 14():81. PubMed ID: 26077117
[TBL] [Abstract][Full Text] [Related]
26. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
[TBL] [Abstract][Full Text] [Related]
27. Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke.
Bushi D; Chapman J; Wohl A; Stein ES; Feingold E; Tanne D
J Neurosci Res; 2018 Aug; 96(8):1406-1411. PubMed ID: 29761540
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019
[TBL] [Abstract][Full Text] [Related]
29. Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
Gioia LC; Kate M; Sivakumar L; Hussain D; Kalashyan H; Buck B; Bussiere M; Jeerakathil T; Shuaib A; Emery D; Butcher K
Stroke; 2016 Jul; 47(7):1917-9. PubMed ID: 27222524
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.
Sugiyama Y; Yagita Y; Oyama N; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
Stroke; 2011 Mar; 42(3):770-5. PubMed ID: 21257824
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation].
Neira V; Corbalán R; Pereira J; Panes O; Garayar B; Aizman A; Llevaneras S; Villarroel L
Rev Med Chil; 2016 Sep; 144(9):1103-1111. PubMed ID: 28060970
[TBL] [Abstract][Full Text] [Related]
32. Anesthesia-Induced Hypothermia Attenuates Early-Phase Blood-Brain Barrier Disruption but Not Infarct Volume following Cerebral Ischemia.
Liu YC; Lee YD; Wang HL; Liao KH; Chen KB; Poon KS; Pan YL; Lai TW
PLoS One; 2017; 12(1):e0170682. PubMed ID: 28118390
[TBL] [Abstract][Full Text] [Related]
33. Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.
Ritzel RM; Pan SJ; Verma R; Wizeman J; Crapser J; Patel AR; Lieberman R; Mohan R; McCullough LD
Mol Vis; 2016; 22():575-88. PubMed ID: 27293375
[TBL] [Abstract][Full Text] [Related]
34. Endostatin expression in neurons during the early stage of cerebral ischemia is associated with neuronal apoptotic cell death in adult hypertensive rat model of stroke.
Hou Q; Ling L; Wang F; Xing S; Pei Z; Zeng J
Brain Res; 2010 Jan; 1311():182-8. PubMed ID: 19941836
[TBL] [Abstract][Full Text] [Related]
35. MLC901 Favors Angiogenesis and Associated Recovery after Ischemic Stroke in Mice.
Gandin C; Widmann C; Lazdunski M; Heurteaux C
Cerebrovasc Dis; 2016; 42(1-2):139-54. PubMed ID: 27099921
[TBL] [Abstract][Full Text] [Related]
36. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
[TBL] [Abstract][Full Text] [Related]
37. Effect of the factor Xa inhibitor rivaroxaban on arterial thrombosis in wild-type and apolipoprotein E-deficient mice.
Wagner NM; Dressel T; Schäfer K; Konstantinides S
Thromb Res; 2012 Nov; 130(5):793-8. PubMed ID: 22281071
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke.
Ichijo M; Ishibashi S; Li F; Yui D; Miki K; Mizusawa H; Yokota T
PLoS One; 2015; 10(9):e0138029. PubMed ID: 26367258
[TBL] [Abstract][Full Text] [Related]
39. Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.
Liu J; Nishida M; Inui H; Chang J; Zhu Y; Kanno K; Matsuda H; Sairyo M; Okada T; Nakaoka H; Ohama T; Masuda D; Koseki M; Yamashita S; Sakata Y
J Atheroscler Thromb; 2019 Oct; 26(10):915-930. PubMed ID: 30867376
[TBL] [Abstract][Full Text] [Related]
40. Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.
Ikeda T; Atarashi H; Inoue H; Uchiyama S; Kitazono T; Yamashita T; Shimizu W; Kamouchi M; Kaikita K; Fukuda K; Origasa H; Sakuma I; Saku K; Okumura Y; Nakamura Y; Morimoto H; Matsumoto N; Tsuchida A; Ako J; Sugishita N; Shimizu S; Shimokawa H
Tohoku J Exp Med; 2016 Dec; 240(4):259-268. PubMed ID: 27904005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
